Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F21%3A00074522" target="_blank" >RIV/65269705:_____/21:00074522 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/21:00121941
Result on the web
<a href="https://www.frontiersin.org/articles/10.3389/fbioe.2021.649446/full" target="_blank" >https://www.frontiersin.org/articles/10.3389/fbioe.2021.649446/full</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3389/fbioe.2021.649446" target="_blank" >10.3389/fbioe.2021.649446</a>
Alternative languages
Result language
angličtina
Original language name
Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study
Original language description
An inability of the human body to heal acute wounds under certain conditions results in the formation of chronic ulcers. Chronic wounds not only cause significant pain and discomfort for patients but also serve as an entry for microorganisms into the human body, which can result in serious life-threatening problems and become a significant burden for the patients and society. The current work present results of a multicentre prospective observational study demonstrating the use of a lyophilized amniotic membrane (AM) in the treatment of chronic wounds (various etiologies). Lyophilized AM produced under the commercial brand Amnioderm (R) was used as an allograft material for therapy of chronic wounds, in addition to chronic ulcer standard-of-care (SoC) protocols. The duration of wounds considered for the application of AM ranged between 2 months and 11 years. In total, 16 patients were enrolled to the study, of which eight were completely healed, six demonstrated a significantly reduced ulcer size, and two did not respond to the AM therapy. The current study unambiguously demonstrates an effective alternative to the standard of chronic wound care and confirms a significant effect of the AM application for chronic wound management as a new SoC.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30200 - Clinical medicine
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Frontiers in Bioengineering and Biotechnology
ISSN
2296-4185
e-ISSN
—
Volume of the periodical
9
Issue of the periodical within the volume
JUN 24
Country of publishing house
CH - SWITZERLAND
Number of pages
11
Pages from-to
649446
UT code for WoS article
000670555700001
EID of the result in the Scopus database
2-s2.0-85109777457